Follow
Sergio Garcia-Fernandez
Sergio Garcia-Fernandez
Hospital Universitario Ramón y Cajal
No verified email
Title
Cited by
Cited by
Year
Cacaoidin, first member of the new lanthidin RiPP family
FJ Ortiz‐López, D Carretero‐Molina, M Sánchez‐Hidalgo, J Martín, ...
Angewandte Chemie International Edition 59 (31), 12654-12658, 2020
872020
Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection
M Ponce-Alonso, JS de la Fuente, A Rincón-Carlavilla, P Moreno-Nunez, ...
Infection Control & Hospital Epidemiology 42 (4), 406-410, 2021
862021
Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two …
S Garcia-Fernandez, MI Morosini, F Marco, D Gijon, A Vergara, J Vila, ...
Journal of Antimicrobial Chemotherapy 70 (4), 1047-1050, 2015
682015
Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: the SUPERIOR multicentre study
S García-Fernández, M García-Castillo, G Bou, J Calvo, E Cercenado, ...
International journal of antimicrobial agents 53 (5), 682-688, 2019
452019
Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain
S García-Fernández, MI Morosini, M Cobo, JR Foruny, ...
Diagnostic microbiology and infectious disease 86 (4), 470-471, 2016
392016
Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario
S García-Fernández, M Frentrup, M Steglich, A Gonzaga, M Cobo, ...
Scientific reports 9 (1), 6959, 2019
372019
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation …
M García-Castillo, S García-Fernández, R Gómez-Gil, C Pitart, M Oviaño, ...
International journal of antimicrobial agents 51 (3), 511-515, 2018
332018
Detection of carbapenemase production in a collection of Enterobacteriaceae with characterized resistance mechanisms from clinical and environmental origins by use of both …
S García-Fernández, MI Morosini, D Gijón, L Beatobe, P Ruiz-Garbajosa, ...
Journal of Clinical Microbiology 54 (2), 464-466, 2016
292016
A publicly accessible database for Clostridioides difficile genome sequences supports tracing of transmission chains and epidemics
M Frentrup, Z Zhou, M Steglich, JP Meier-Kolthoff, M Göker, T Riedel, ...
Microbial Genomics 6 (8), e000410, 2020
272020
Evaluation of a loop-mediated isothermal amplification-based methodology to detect carbapenemase carriage in Acinetobacter clinical isolates
A Vergara, Y Zboromyrska, N Mosqueda, MI Morosini, ...
Antimicrobial Agents and Chemotherapy 58 (12), 7538-7540, 2014
252014
Performance of CHROMID® Colistin R agar, a new chromogenic medium for screening of colistin-resistant Enterobacterales
S García-Fernández, M García-Castillo, P Ruiz-Garbajosa, MI Morosini, ...
Diagnostic Microbiology and Infectious Disease 93 (1), 1-4, 2019
222019
In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in …
S García-Fernández, M García-Castillo, J Melo-Cristino, MF Pinto, ...
International journal of antimicrobial agents 55 (3), 105887, 2020
202020
CHROMagar mSuperCARBA performance in carbapenem-resistant Enterobacteriaceae isolates characterized at molecular level and routine surveillance rectal swab specimens
S García-Fernández, M Hernández-García, A Valverde, P Ruiz-Garbajosa, ...
Diagnostic Microbiology and Infectious Disease 87 (3), 207-209, 2017
202017
Multicenter evaluation of the new Etest gradient diffusion method for piperacillin-tazobactam susceptibility testing of Enterobacterales, Pseudomonas aeruginosa, and …
S García-Fernández, Y Bala, T Armstrong, M García-Castillo, ...
Journal of clinical microbiology 58 (2), 10.1128/jcm. 01042-19, 2020
192020
Confronting ceftolozane-tazobactam susceptibility in multidrug-resistant Enterobacterales isolates and whole-genome sequencing results (STEP study)
M Hernández-García, S García-Fernández, M García-Castillo, ...
International journal of antimicrobial agents 57 (2), 106259, 2021
172021
Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
R Escudero-Sánchez, M Ruiz-Ruigómez, J Fernández-Fradejas, ...
Journal of Clinical Medicine 10 (1), 2, 2020
172020
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain …
M Hernández-García, M García-Castillo, S García-Fernández, ...
Journal of Antimicrobial Chemotherapy 76 (2), 370-379, 2021
162021
Presence of Chromosomal crpP-like Genes Is Not Always Associated with Ciprofloxacin Resistance in Pseudomonas aeruginosa Clinical Isolates Recovered in …
M Hernández-García, M García-Castillo, S García-Fernández, ...
Microorganisms 9 (2), 388, 2021
122021
WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain
M Hernández-García, S García-Fernández, M García-Castillo, G Bou, ...
JAC-Antimicrobial Resistance 2 (4), dlaa084, 2020
102020
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP …
M Hernández-García, M García-Castillo, J Melo-Cristino, MF Pinto, ...
Journal of Antimicrobial Chemotherapy 77 (11), 3163-3172, 2022
92022
The system can't perform the operation now. Try again later.
Articles 1–20